Unlocking thalidomide response as a hemoglobin F augmentation agent in transfusion-dependent β-thalassemia: the genetic impact of BCL11A, HBS1L-MYB, and XmnI polymorphism

Diagnostic Pathology · Published 2026-07-07 · DOI 10.1186/s13000-026-01797-5

Free full text

Authors (4)

Iram Nazir, Muhammad Younus Jamal Siddiqi, Maeesa Wadood, Muhammad Rizwan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Nazir, I., Siddiqi, M., Wadood, M., et al. (2026). Unlocking thalidomide response as a hemoglobin F augmentation agent in transfusion-dependent β-thalassemia: the genetic impact of BCL11A, HBS1L-MYB, and XmnI polymorphism. Diagnostic Pathology. https://doi.org/10.1186/s13000-026-01797-5

Related articles